RadNet, Inc., provides outpatient imaging services in the United States. The company is headquartered in Los Angeles, California.
| Revenue (TTM) | $2.27B |
| Gross Profit (TTM) | $392.17M |
| EBITDA | $276.15M |
| Operating Margin | 7.89% |
| Return on Equity | 1.50% |
| Return on Assets | 1.70% |
| Revenue/Share (TTM) | $29.52 |
| Book Value | $13.94 |
| Price-to-Book | 5.61 |
| Price-to-Sales (TTM) | 2.64 |
| EV/Revenue | 3.352 |
| EV/EBITDA | 22.55 |
| Quarterly Earnings Growth (YoY) | -49.10% |
| Quarterly Revenue Growth (YoY) | 25.00% |
| Shares Outstanding | $78.70M |
| Float | $65.76M |
| % Insiders | 9.96% |
| % Institutions | 105.34% |
Volatility is currently expanding
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for RadNet (RDNT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.
RadNet (RDNT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RadNet, Inc. (RDNT) M&A Call Transcript
RadNet announces agreement to acquire ONRAD, combining radiology professional services, AI solutions and outpatient imaging into an integrated offering.
SOMERVILLE, Mass., Oct. 08, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced new findings published in European Radiology supporting that AI applications within DeepHealth's Prostate MR Solution1 could help clinicians decide more confidently which men may need a prostate biopsy, particularly when MRI findings are uncertain.2 Prostate cancer is the second most commonly diagnosed cancer among men worldwide, with an estimated 1.55 million new cases in 2024.3 MRI helps clinicians assess whether prostate cancer may be present, but some findings remain uncertain.4 A biopsy involves collecting small tissue samples to check for cancer and, if found, assess its grade.
New program introduces students and young adults to careers in radiology through mentorship, digital experiences and hands-on learning. OWINGS MILLS, Md.
RadNet, Inc. (RDNT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026 at 07:45 a.m. Eastern Time.
LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 442 outpatient imaging centers and a premier developer of radiology digital health solutions, today announced it will host a free webinar for patients and the general public on Saturday, September 19, 2026, in support of Prostate Cancer Awareness Month.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on RDNT and any ticker you trade — then tracks every position and per-strategy win rate.
